Cargando…
First-in-Class Oral Semaglutide: Overcoming Barriers of Incretinisation in the Indian Context
Despite the availability of multiple therapeutic options and strategies, patients with type 2 diabetes mellitus (T2DM) the world over have inadequate glycaemic control and India is no exception. Patients with T2DM in India have benefitted from glucagon-like peptide-1 analogues similar to that of pat...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815186/ https://www.ncbi.nlm.nih.gov/pubmed/36618518 http://dx.doi.org/10.4103/ijem.ijem_217_22 |